| PT Kimia Farma Tbk | |
| Foundation: | 1971 |
| Products: | pharmacy |
| Industry: | Pharmaceuticals |
| Revenue: | Rp 9.400 trillion (2019) |
| Net Income: | Rp 15.89 billion (2019) |
| Assets: | Rp 18.352 trillion (2019) |
| Equity: | Rp 7.412 trillion (2019) |
| Num Employees: | 13,052 (2019) |
| Owner: | Bio Farma |
| Homepage: | www.kimiafarma.co.id |
PT Kimia Farma Tbk is an Indonesian pharmaceutical producer and distributor in Indonesia. It is based in Jakarta.[1]
In 1957, Dutch-owned pharmaceutical firms were nationalized by the Government of the Republic of Indonesia. Nationalized firms included N. V. Pharmaceutische Handelsvereeniging J. van Gorkom & Co., (Jakarta), N. V. Chemicaliënhandel Rathkamp & Co., (Jakarta),[2] N. V. Bandoengsche Kininefabriek, (Bandung),[3] N. V. Jodium Onderneming Watoedakon (Mojokerto) and N. V. Verbandstoffenfabriek (Surakarta).[4]
Following Government Regulation no. 69 in 1968 the resulting firms were named State Pharmaceutical Companies (PNF) named PNF Radja Farma (Jakarta), PNF Conscience Farma (Jakarta), PNF Nakula Farma (Jakarta), PNF Bio Farma, State Enterprise (PN) Bhineka Kina Farma (Bandung), PN Sari Husada (Yogyakarta) and PN Pharmaceuticals and medical devices Kasa Husada (Surabaya).
On 23 January 1969, based on PP. 3 In 1969 the companies merged into PNF Bhineka Kimia Farma. On 16 August 1971, the State Pharmaceutical companies transition Kimia Farma's legal form into State Owned status as a Limited Liability Company, becoming PT. Kimia Farma (Persero).
In 1998, the Asian economic crisis resulted in the state budget experiencing growing national debt. To reduce the burden of debt, the government began privatizating state-owned firms. Based on the Letter of Minister of State for Investment and Development, S-59/M-PM.BUMN/2000 dated 7 March 2000, PT. Kimia Farma privatized.
The directors of PT. Kimia Farma (Limited) established two subsidiaries on the 4 January 2002, PT. Pharmacy and PT Kimia Farma. Kimia Farma Trading and Distribution. On 4 July 2002 PT. Kimia Farma Tbk. officially listed on the Jakarta Stock Exchange (JSX) and the Surabaya Stock Exchange (BES) as a public company and changed its name to PT. Kimia Farma (Persero), Tbk.
In May 2021, a local Medan manager and four other employees working for Kimia Farma were arrested for washing and reusing COVID-19 nasal cotton swabs up to 20,000 times on 9,000 passengers flying through Kualanamu International Airport since December 2020.[5] The workers were suspected to have pocketed as much as 1.8 billion Indonesian rupiah (~$125,000 USD), some of which allegedly went toward a lavish house for one of the suspects.[6] While Kimia Farma has fired the employees-in-question, two human rights lawyers, Ranto Sibarani and Kamal Pane, who were frequent fliers during the time period, have filed a lawsuit against the firm, seeking damages of Rp. 1 billion (~$69,000 USD) per affected passenger.[7] [8]
Five production facilities spread across major cities in Indonesia manufacture pharmaceuticals.[9]
Kimia Farma planned to open a branch drugstore in Malaysia, as revealed in 2012.[10]